They reported that the overexpression of Gal-1 was associated with lower OS (HR: 1.79, 95% CI: 1.54–2.08, p < 0.001), suggesting its potential as a prognostic factor in malignant tumors, particularly in digestive cancers. Here, LGALS1 is linked to cancer.